Myeloproliferative Disorders clinical trials at UCSF
1 research study open to eligible people
Myeloproliferative disorders are blood diseases in which bone marrow overproduces blood cells. UCSF is running trials that study targeted drugs and monitor blood counts and symptoms. UCSF is involved in an international registry testing whether an AI program can match patients to trials and record outcomes.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
open to all eligible people
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
San Francisco, California and other locations
Last updated: